Trial Profile
Histologic changes of fibrovascular membrane associated with proliferative diabetic retinopathy after intravitreal bevacizumab (Avastin)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 09 Feb 2007 New trial record.